Abstract Fragile X-associated tremor ataxia syndrome (FXTAS) is caused by FMR1 premutation. The features include ataxia, action tremor and middle cerebellar peduncle (MCP) hyperintensity, the latter being the only major radiological criterion in the diagnosis of definite FXTAS until very recently. The importance of corpus callosum splenium (CCS) hyperintensity was recently reported and this sign is now considered as an additional major radiological diagnostic criterion in the diagnosis of FXTAS. However, little is known about its relevance for the diagnosis of FXTAS in clinical practice. We report a practical justification of the relevance of CCS hyperintensity in parallel with MCP hyperintensity for the diagnosis of FXTAS. Clinical and radiological study of 22 FMR1 premutation carriers with neurological signs that may be encountered in FXTAS compared to series of patients with essential tremor, multiple system atrophy of cerebellar type, Parkinson's disease, Alzheimer's disease and stroke. Among the 22 patients with FMR1 premutation [17 men, 5 women; mean age, 63 ± 7.5 (46-84)], 14 were diagnosed with definite FXTAS with the initial criteria. Considering CCS hyperintensity as a new major radiological criterion permitted the diagnosis of definite FXTAS in 3 additional patients. Overall CCS proved as frequent as MCP hyperintensity (64 versus 64 %), while 23 % of patients had CCS but not MCP hyperintensity, 14 % of patients had CCS hyperintensity but neither MCP, nor brainstem hyperintensity. In contrast with CCS hyperintensity, MCP hyperintensity proved less frequent in women than in men.
Introduction
Fragile X-associated tremor ataxia syndrome (FXTAS) is an X-linked disorder due to FMR1 premutation, which corresponds to a repeat expansion between 55 and 200 CGG triplets [1] [2] [3] . Full mutations (C200 CGG) of FMR1 cause fragile X syndrome (FXS). FXTAS is a complex neurodegenerative disease which affects men (more frequently than women) with the premutation occurring between 50 and 80 years of age with an average age at onset of around 60 years. It is characterized by progressive cerebellar ataxia and action tremor with classical but optional middle cerebellar peduncle (MCP) FLAIR hyperintensities [1] [2] [3] [4] [5] [6] [7] . Seemingly neglected due to its broad phenotypic spectrum, [8] it is crucial in clinical practice to diagnose FXTAS for an optimum management of the patient and subsequent genetic counselling of the relatives. The diagnosis of FXTAS relies on a combination of major and minor clinical and MRI criteria. In the initial criteria, the only major radiological criterion considered in the diagnosis of definite FXTAS was MCP and/or brainstem hyperintensity, signs that can nevertheless be lacking in up to 30 % of FXTAS patients [2] and that are not specific of FXTAS [9] . We recently reported that a hyperintensity of the corpus callosum splenium (CCS) could assist in identifying more FXTAS patients and if effective should then be considered as a novel major radiological criterion [10] .
More recently, the criteria for the diagnosis of FXTAS have been revised by an expert group, including CCS as an additional major radiological criterion [11] . Our aim here is to report a practical justification of the relevance of CCS hyperintensity in parallel with MCP hyperintensity for the diagnosis of FXTAS in a new cohort of patients, to support the revision of the diagnosis criteria for FXTAS and to better define the value of the CCS sign.
Methods
Between April 2012 and July 2013 we included in the study the patients that were consecutively referred in 7 French neurology centres (Strasbourg, Montpellier, Marseille, Bordeaux, Nantes, Grenoble and Saint Malo) demonstrating the combination of FMR1 premutation and neurological signs that may be encountered in FXTAS. No preferential recruitment of families expressing FXS was made [2, 8] .
Clinical examination
Clinical data were collected via retrospective review of the patients' records. Neurological examination was performed by a neurologist experienced in the field of movement disorders. Examination included a comparative Scale for the Assessment and Rating of Ataxia (SARA) which has been validated for inherited ataxias [12] , frontal assessment battery (FAB) [13] and mini-mental state examination (MMSE) [14] scores.
Brain MRI
Brain MRI were recorded for the 22 suspected FXTAS patients as well as for 19 patients consecutively diagnosed with multiple system atrophy of cerebellar type (MSA-C) who were negative for FMR1 premutation, 24 patients consecutively diagnosed with essential tremor (ET) who were negative for FMR1 premutation, 30 patients consecutively diagnosed with Parkinson's disease (PD), 22 patients consecutively diagnosed with Alzheimer's disease (AD) and 30 patients consecutively diagnosed with stroke. A comparative, qualitative analysis was performed especially regarding the hyperintensities of periventricular white matter, of the pons, the MCP and the CCS in all these groups. All patients underwent 1.5 T MRI including T1, T2-weighted, and T2 FLAIR images, the latter being considered as the standard for the identification of white matter hyperintensities in FXTAS [10] . Image acquisition was performed in axial, sagittal and coronal planes. The FXTAS patients underwent the MRI in the center they were referred to and the neuroradiologist of each center blindly red the MRI. All the MRI were then read by a neurologist expert in the field of FXTAS. The MRI of the MSA-C, ET, PD, AD and stroke were performed in Strasbourg and assessed by a neuroradiologist and then by a neurologist.
Electromyography
Electromyography was performed as previously described [10] . FMR1 molecular analysis PCR reactions were realized as previously reported [15] with primer kit PR155 and PR156; PCR products were further analysed by automated fragment analysis in a 3730xl DNA Analyser (Applied Biosystems, Foster City, CA, USA), for assessment of repeat number. Alleles with 55-199 CGG repeats were defined as premutation alleles.
FXTAS diagnostic category
With respect to the clinical, radiological and molecular findings, the diagnosis of FXTAS was established according to the initial FXTAS diagnostic category [2, 8] (with MCP and/or brainstem hyperintensity as the only major radiological criterion) as well as according to the recently proposed new diagnosis criteria taking into account CCS hyperintensity as an additional major radiological criteria [10, 11] .
Statistical methods
The statistical analyses included both descriptive and analytical sections. The descriptive section presented the frequency of each value and the cumulative frequency for the qualitative variables along with the mean and standard deviation for the quantitative variables. For the quantitative variables, normality of distribution was verified using the Shapiro-Wilk test. The analytical section was performed under the Bayesian paradigm. Comparisons between qualitative variables were made using logistical regressions while those between quantitative and qualitative variables used linear regressions. Variables that had a bivariate 95 % posterior probability to be different from 0 were considered for multivariate analyses. The analyses were made with R 3.0.0 software and with R2WinBUGS package. Comparisons between different groups (FXTAS, MSA-C, ET, PD, AD and stroke) were performed with v 2 test.
Standard protocol approvals, registrations and patient consents
Local ethics committees approved the study and all participants being informed gave written consent.
Results
Twenty-two patients (17 men; 5 women) were included.
Demographics and clinical characteristics
The main demographic, clinical, molecular and radiological data are presented in Table 1 . While CCS hyperintensity was found in 11/17 men and 3/5 women, MCP hyperintensity was found in 14/17 men and 0/5 women and brainstem hyperintensity found in 7/17 men and 2/5 women (2 patients had brainstem hyperintensity but no MCP hyperintensity and finally 14/17 men and 2/5 women had MCP and/or brainstem hyperintensity). MCP hyperintensity was more frequent in men than in women, while for CCS hyperintensity the gender ratio approached unity. According to the initial criteria of Jacquemont et al. [2] the diagnosis of FXTAS was definite in 14 patients (13 men and one woman), probable in 4 patients (2 men and 2 women) and possible for one woman. Three patients did not meet the criteria of possible FXTAS (2 men and one woman) even if they had both neurological signs that may be encountered in FXTAS (cognitive decline and/or fibromyalgia for instance) [2] , abnormal MRI findings (CSS or MCP hyperintensity) and FMR1 premutation. Considering CCS hyperintensity as a new major clinical sign [11] , the diagnosis of FXTAS was definite in 17 patients (15 men and 2 women), probable in 2 patients (2 women), possible for no patients. Two men and one woman still could not meet the criteria for possible FXTAS.
Radiological and neurophysiologic results
The principal radiological and neurophysiological data of premutation carriers are presented in Table 1 and Fig. 1 . The neuroradiologists and the neurologists found the same abnormalities in all patients. The results of the comparison between FXTAS and the neurodegenerative diseases (MSA-C, ET, PD and AD) as well as stroke are provided in Table 2 . The combination of CCS and MCP hyperintensity was found in 41 % of FXTAS patients and was more frequent in FXTAS than in ET (p \ 0.001), PD (p \ 0.001), AD (p \ 0.001), MSA-C (p = 0.001) and stroke (p \ 0.001). In two FXTAS patients, the CCS hyperintensity affected the lower part of the splenium of the corpus callosum (Fig. 1c) , which was never found in the patients with MSA-C, ET, PD, AD and stroke.
Correlation between clinical, morphologic and molecular data Middle cerebellar peduncle hyperintensity was more frequent in men than in women [OR = 50.55, 95 % CI 
Discussion
In our series, CCS hyperintensity proved as frequent as MCP hyperintensity. Consideration for the inclusion of CCS as another major radiological sign in the diagnosis of FXTAS is supported by the identification of 5 patients who FAB frontal assessment battery, FXS fragile X syndrome, FXTAS fragile X-associated tremor ataxia syndrome, MMSE mini-mental state examination, POI primary ovarian insufficiency, SARA Scale for the Assessment and Rating of Ataxia were negative for MCP hyperintensity yet were authentic FXTAS cases (23 % of patients in our series). Equally, using this radiological sign as a major criterion, 3 more premutation carriers were diagnosed with definite FXTAS which led to the initiation of genetic counselling for these supplementary patients as well as their relatives, thus improving their management in clinical practice. The presence of CCS and/or MCP hyperintensity appears to be a sensitive morphological marker for FXTAS. The combination of MCP and CCS hyperintensities, not at all uncommon, could be very specific for FXTAS (almost pathognomonic). The CCS hyperintensity is suggestive of FXTAS in patients with chronic neurological signs such as ataxia, tremor, Parkinsonism and/or cognitive decline since the sign has been less frequently identified in neurodegenerative diseases such as MSA-C, ET, PD and AD, respectively. FMR1 premutation was excluded in the ET control group as well as in MSA-C but not in PD and AD, even if it has been reported that FMR1 premutation were particularly scarce in all these diseases. Regarding the frequency of CCS hyperintensity, only a trend towards a difference between FXTAS and stroke has been found probably due to the small size of the cohort. Moreover, both patients with FXTAS and stroke shared frequent vascular risk factors (although hypertension was more frequent in stroke). Vascular risk factors are common in FXTAS due to the mean age at onset, the sex ratio and the frequent combination with hypertension, sleep apnoea and cardiac arrhythmia [8] . Whether vascular risk factors contribute to the appearance of neurological signs in FXTAS remains to be studied. Finally, CCS hyperintensity may also be seen in some patients with stroke in the same way that MCP hyperintensity may be encountered in MSA-C. However, stroke is not a differential diagnosis of FXTAS in clinical practice, which is not true for MSA-C. Taken together, these findings strongly support the addition of CCS hyperintensity to the diagnosis criteria as a new major MRI criterion [10] . In our cohort, MCP hyperintensity was found only in 16 % of MSA-C possibly because patients had a mean evolution of only 3 years. Thus, MCP was found to be more frequent in FXTAS than in MSA-C which needs to be confirmed by further larger prospective studies. Whereas MCP hyperintensity was observed in only 13 % of FXTAS women in a previous series [16] , no women in our study presented MCP hyperintensity. Alternately, 3 of the 5 women of our series had CCS hyperintensity. This finding further strengthens the interest of the CCS sign in the clinical practice and especially for the diagnosis of women with FXTAS. Interestingly, in our series MCP hyperintensity was correlated with tremor as the first sign of FXTAS. As the MCP carry the cortico-pontine afferences to the cerebellum, they could be responsible for action tremor when damaged.
Herein, brainstem hyperintensities was found to be equally frequent in FXTAS and in MSA-C and PD which may be considered as differential diagnosis of FXTAS. This is consistent with the fact that brainstem hyperintensity is only a minor radiological criterion.
Tremor may be lacking in FXTAS. Among our patients, 23 % had initial isolated ataxia and 18 % initial isolated mild cognitive impairment. So, FXTAS should be searched for in the case of mild cognitive impairment in the elderly especially if brain MRI demonstrates CCS and/or MCP hyperintensity.
In our series, 55 % of patients had polyneuropathy, which is close to other studies [17] and supports polyneuropathy as minor FXTAS clinical criteria [11] . Indeed, polyneuropathy may be the first sign of the disease [17] . Herein, CGG repeat number was correlated with Parkinsonism as the first sign of the disease, which further highlights the value of Parkinsonism in FXTAS [1, 10] .
Our series is limited because it was retrospective, multicentric, non exhaustive and based on only 22 new patients who underwent standard brain MRI though it should enhance support for the relevance of CCS hyperintensity as well as its inclusion in the diagnostic criteria as a novel major radiological criterion. A further and broader prospective study, using FXTAS motor rating scale [18] , is required to strengthen and render more accurate these data. Moreover, more precise MRI investigations [19] are needed to learn whether some CCS, MCP and/or brainstem MRI abnormalities are due to normal ageing, or if a sub-group of these abnormalities are particularly suggestive of FXTAS. Indeed, the diagnosis of FXTAS is crucial in clinical practice for an optimum management of the patient and the provision of genetic counselling for the relatives.
